Conclusion

In conclusion, further investigations on IgG4-RND patients should be performed, focusing on the diagnosis. Early recognition of IgG4-RND can help avoid system dysfunction and disability in the nervous system and other organs of the body due to its potential for guiding the diagnosis of other co-occurring conditions. We should include it in the differential diagnosis of possible cases because despite responding to treatments, its potential risks are as of yet unknown.
References
1. Stone JH, Zen Y, Deshpande V. IgG4-Related Disease. New England Journal of Medicine. 2012;366(6):539-551.
2. Nilles C, Poillon G, Deschamps L, et al. IgG4-related pachymeningitis and mastoiditis, associated with cerebral venous thrombosis: A case report. Journal of Neuroimmunology. 2021;360:577717.
3. Deshpande V, Zen Y, Chan JKC, et al. Consensus statement on the pathology of IgG4-related disease. Modern Pathology.2012;25(9):1181-1192.
4. Vasaitis L. IgG4-related disease: A relatively new concept for clinicians. European Journal of Internal Medicine. 2016;27:1-9.
5. Wallace ZS, Naden RP, Chari S, et al. The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease. Arthritis & rheumatology (Hoboken, NJ). 2020;72(1):7-19.
6. AbdelRazek MA, Venna N, Stone JH. IgG4-related disease of the central and peripheral nervous systems. The Lancet Neurology.2018;17(2):183-192.
7. Perez FA. Imaging of Nontraumatic Orbital and Neuro-ophthalmological Emergencies. Paper presented at: Seminars in Roentgenology2020.
8. Shimatsu A, Oki Y, Fujisawa I, Sano T. Pituitary and stalk lesions (infundibulo-hypophysitis) associated with immunoglobulin G4-related systemic disease: an emerging clinical entity. Endocrine journal.2009;56(9):1033-1041.
9. Ekizoglu E, Coban O, Ulukan C, et al. Intracranial hypertension related to cerebral venous thrombosis; and acute ischemic stroke with micro-infarcts associated with IgG4-related disease. International Journal of Neuroscience. 2018;128(11):1097-1099.
10. Joshi D, Jager R, Hurel S, et al. Cerebral involvement in IgG4-related disease. Clin Med (Lond). 2015;15(2):130-134.
11. Liu Y, Xue F, Yang J, Zhang Y. Immunoglobulin G4-related disease mimicking lymphoma in a Chinese patient. Rheumatology International. 2015;35(10):1749-1752.
12. Lu LX, Della-Torre E, Stone JH, Clark SW. IgG4-Related Hypertrophic Pachymeningitis: Clinical Features, Diagnostic Criteria, and Treatment.JAMA Neurology. 2014;71(6):785-793.
13. Fujita A, Sakai O, Chapman MN, Sugimoto H. IgG4-related Disease of the Head and Neck: CT and MR Imaging Manifestations.RadioGraphics. 2012;32(7):1945-1958.
14. Della-Torre E, Galli L, Franciotta D, et al. Diagnostic value of IgG4 Indices in IgG4-related hypertrophic pachymeningitis. Journal of neuroimmunology. 2014;266(1-2):82-86.
15. Liu A, Zhang Q, Liu B, Xu N, Li A. A case of immunoglobulin G4-related lung disease with bilateral diffuse infiltration: A case report. Medicine (Baltimore). 2017;96(50):e9211.
16. Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med.2001;344(10):732-738.
17. Blockmans D. IgG4-related disease. Acta Clin Belg.2018;73(1):11-15.
18. Sireesha Y, Uppin MS, Ganti S, et al. A Series of Biopsy-proven Patients with Immunoglobulin G4-related Neurological Disease. Ann Indian Acad Neurol. 2019;22(1):73-78.
19. Baptista B, Casian A, Gunawardena H, D’Cruz D, Rice CM. Neurological Manifestations of IgG4-Related Disease. Curr Treat Options Neurol. 2017;19(4):14.
20. Inoue D, Yoshida K, Yoneda N, et al. IgG4-related disease: dataset of 235 consecutive patients. Medicine (Baltimore).2015;94(15):e680.
21. Lin W, Lu S, Chen H, et al. Clinical characteristics of immunoglobulin G4-related disease: a prospective study of 118 Chinese patients. Rheumatology (Oxford). 2015;54(11):1982-1990.
22. Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012;366(6):539-551.
23. Vasaitis L. IgG4-related disease: A relatively new concept for clinicians. Eur J Intern Med. 2016;27:1-9.